ECOLAB’s 2025 Pulse‑Protein Growth: Strong Cash Flow Meets Governance and Liquidity Risks
ECOLAB’s 2025 Form 5A shows steady pulse‑sales growth but mounting debt, cap‑ex pressure and governance risks—what investors must weigh for future value.
4 minutes to read









